ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough lung cancer
Disease control OngoingThis study tested a combination of two drugs, afatinib and prednisone, in 12 people with advanced squamous non-small cell lung cancer that had already been treated. The goal was to see if the combination could slow cancer growth and improve survival. The approach targets cancer c…
Matched conditions: ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated May 17, 2026 09:28 UTC
-
Can old medical records replace new drug trials? lung cancer study aims to find out
Knowledge-focused OngoingThis study looks at medical records from over 800 people with advanced lung cancer to see if they can recreate the results of two earlier clinical trials. The goal is not to test a new treatment, but to learn whether real-world data can be trusted for future research. Participant…
Matched conditions: ADVANCED SQUAMOUS NON SMALL CELL LUNG CANCER
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 09:25 UTC